[1]Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2): 165-228.
[2]Sertaridou E, Papaioannou V, Kolios G, et al. Gut failure in critical care: old school versus new school [J]. Ann Gastroenterol, 2015, 28(3): 309-322.
[3]Riabov V, Gudima A, Wang N, et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis [J]. Front Physiol, 2014, 5: 75.
[4]Stark RJ, Choi H, Koch SR, et al. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A [J]. Clin Sci (Lond), 2016, 130(6): 451-461.
[5]Freemerman AJ, Johnson AR, Sacks GN, et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype [J]. J Biol Chem, 2014, 289(11): 7884-7896.
[6]Cao Y, Chen Q, Wang Z, et al. PLK1 protects against sepsis-induced intestinal barrier dysfunction [J]. Sci Rep, 2018, 8(1): 1055.
[7]Yang J, Wan Y, Liu H, et al. C2-ceramide influences alveolar epithelial barrier function by down-regulating Zo-1, occludin and claudin-4 expression[J]. Toxicol Mech Methods, 2017: 1-21.
[8]Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 9-21.
[9]Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness [J]. Crit Care Clin, 2016, 32(2): 203-212.
[10]Diezmos EF, Bertrand PP, Liu L. Purinergic signaling in gut inflammation: the role of connexins and pannexins [J]. Front Neurosci, 2016, 10: 311.
[11]Chiu YH, Lu YC, Ou CC, et al. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells[J]. BMC Microbiol, 2013, 13: 190.
[12]Ben YA, Lichtenstein Y, Zolotarov L, et al. The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis [J]. BMC Gastroenterol, 2015, 15: 154.
[13]Alvarez PGA, Barbosa NL, Patipo VM, et al. Anti-inflammatory and antinociceptive activities of the ethanolic extract of Bougainvillea xbuttiana [J]. J Ethnopharmacol, 2012, 144(3): 712-719.
[14]Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance [J]. Nat Rev Immunol, 2013, 13(10): 709-721.
[15]Paul AT, Gohil VM, Bhutani KK. Modulating TNF-alpha signaling with natural products[J]. Drug Discov Today,2006,11(15-16):725-732.
[16]Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer[J]. Cancer Cell,2009,15(2):103-113.
[17]Ray S, Ju X, Sun H, et al. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar[J]. J Invest Dermatol,2013,133(5):1212-1220.
[18]Park JH, Lee WR, Kim HS, et al. Protective effects of melittin on tumor necrosis factor-alpha induced hepatic damage through suppression of apoptotic pathway and nuclear factor-kappa B activation[J]. Exp Biol Med (Maywood),2014,239(12):1705-1714.
[19]李续博, 姜广宇, 赵旭. 川芎嗪对单核细胞系THP-1细胞TLR7/NF-κB表达的影响[J]. 医药导报, 2018, 37(10): 1174-1178.
[20]Yu X, Jia B, Wang F, et al. alpha(1) adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-alpha production via modulating ERK1/2 and NF-kappaB pathway[J]. J Cell Mol Med, 2014, 18(2): 263-273.
[21]Rothwarf DM, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus [J]. Sci STKE, 1999, 1999(5): E1. |